The government plans to introduce lenacapavir, a long-acting injectable drug for HIV prevention, in the last quarter of the year, according to Rwanda Biomedical Centre (RBC). The injection, given once ...

The U.S. has approved the world’s only twice-a-year shot to prevent HIV, maker Gilead Sciences announced Wednesday. It's the first step in an anticipated global rollout that could protect millions – ...